ArticleClinical, cosmetic and investigational dermatology2025

Improvement of Low-Dose Abrocitinib-Resistant Lichen Amyloidosis with Dupilumab: Two Case Reports.

Wenxin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.